Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.58 - $1.13 $15,380 - $29,965
-26,518 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.66 - $2.64 $1,990 - $3,165
-1,199 Reduced 4.33%
26,518 $44,000
Q2 2021

Aug 16, 2021

BUY
$2.7 - $3.81 $19,005 - $26,818
7,039 Added 34.04%
27,717 $92,000
Q1 2021

May 17, 2021

BUY
$3.02 - $5.16 $8,990 - $15,361
2,977 Added 16.82%
20,678 $69,000
Q4 2020

Feb 16, 2021

BUY
$2.66 - $4.18 $47,084 - $73,990
17,701 New
17,701 $67,000
Q2 2020

Aug 14, 2020

SELL
$2.33 - $4.6 $36,380 - $71,824
-15,614 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.57 - $4.08 $4,451 - $7,066
1,732 Added 12.48%
15,614 $64,000
Q3 2019

Nov 14, 2019

SELL
$2.74 - $4.65 $5,764 - $9,783
-2,104 Reduced 13.16%
13,882 $45,000
Q2 2019

Aug 14, 2019

BUY
$2.66 - $6.28 $42,522 - $100,392
15,986 New
15,986 $59,000

Others Institutions Holding MBIO

About MUSTANG BIO, INC.


  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $22.1M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.